Sentinel’s “IMPACT” Beyond Safety: Anti-Coagulant Study Is Early Test
This article was originally published in RPM Report
Executive Summary
The Sentinel post-marketing surveillance system is up and running. Now, FDA is ready to explore uses beyond safety.